newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. to Participate in Upcoming Investor Conferences

  • Exagen Inc. (NASDAQ: XGN) announced management will participate in two upcoming investor conferences.
  • The company will present at Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum in New York, NY, on November 11, 2026.
  • Management will present on the panel "Innovative Diagnostics for Attractive Immunology Applications" at 10:30am ET during the Canaccord Genuity event.
  • Exagen will attend Craig-Hallum's Alpha Select Conference in New York, NY, on November 17, 2026.
  • Exagen Inc. operates a CLIA-certified, CAP-accredited rheumatology laboratory based in San Diego County, California.
  • The company's flagship test, AVISE® CTD, provides diagnostic clarity for autoimmune conditions including lupus, rheumatoid arthritis, & Sjögren's disease.
  • Tina Jacobsen, CFA, serves as the investor relations contact for Exagen Inc.